nach oben

Supportive Care in Cancer

Erschienen in:

03.06.2018 | Original Article

Complementary and alternative medicine (CAM) information and support needs of Chinese-speaking cancer patients

verfasst von: Lynda G. Balneaves, M. E. Wong, A. J. Porcino, T. L. O. Truant, S. E. Thorne, S. T. Wong

Erschienen in: Supportive Care in Cancer | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Complementary and alternative medicine (CAM) is popular among Chinese-speaking cancer patients (CSCPs), but little research examines CAM use by Canadian CSCPs. The use of CAM is controversial because of potential interactions with conventional cancer treatments. The purpose of this study was to explore CSCPs’ use of CAM, sources of CAM information, and decision support needs, as well as their experience of making CAM decisions.

Methods

A sequential, multi-method research design was used: a secondary data analysis of a CAM use survey conducted in a Western Canadian regional cancer agency followed by a qualitative interpretive description approach to inquiry using semi-structured interviews with CSPCs and support persons.

Results

More than 65% of CSCPs reported using CAM. CSCPs favored biologically-based therapies, including traditional Chinese medicine herbs and other natural health products. Many CSCPs were using CAM without adequate culturally appropriate information and decision support. Those who made decisions spontaneously relied on peers for advice whereas deliberate decision makers sought information from multiple sources, including peers and the Internet, selecting therapies congruent with their cultural health perspectives and previous experiences with CAM. CSCPs rarely spoke with oncology healthcare providers (HCPs) about CAM use.

Conclusions

CSCPs reported using CAM at rates significantly higher than for non-CSCPs. Given the predominance of biological-based therapies and the lack of consultation with oncology HCPs, it is imperative that CAM use be assessed and documented to ensure CSCPs’ safety during cancer treatment. Culturally appropriate information and decision support is required to ensure that CSCPs are making safe and informed CAM decisions.

Boon HS, Olatunde F, Zick SM (2007) Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health 7:4. https://doi.org/10.1186/1472-6874-7-4 CrossRefPubMedPubMedCentral

Verhoef MJ, Trojan J, Armitage GD, Carlson L, Hilsden RJ (2009) Complementary therapies for cancer patients: assessing information use and needs. Chronic Dis Can 29(2):80–88PubMed

Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M (2012) How many cancer patients use complementary and alternative medicine: a systematic review and meta analysis. Integr Cancer Ther 11:187–203. https://doi.org/10.1177/1534735411423920 CrossRefPubMed

Sewitch MJ, Yaffe M, Maisonneuve J, Prchal J, Ciampi A (2011) Use of complementary and alternative medicine by cancer patients at a Montreal hospital. Integr Cancer Ther 10(4):305–311. https://doi.org/10.1177/1534735410395136 CrossRefPubMed

Balneaves LG, Weeks L, Seely D (2008) Patient decision-making about complementary and alternative medicine in cancer management: context and process. Curr Oncol 15(Suppl 2):s94–s100. https://doi.org/10.3747/co.v15i0.280 CrossRefPubMedPubMedCentral

King N, Balneaves LG, Levin GT, Nguyen T, Nation JG, Card C, Truant TLO, Carlson LE (2015) Surveys of cancer patients and cancer health care providers regarding complementary therapy use, communication, and information needs. Integr Cancer Ther 14(6):515–524. https://doi.org/10.1177/1534735415589984 CrossRefPubMed

Evans M, Shaw A, Thompson EA, Falk S, Turton P, Thompson T, Sharp D (2007) Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used. BMC Complement Altern Med 7(25):25. https://doi.org/10.1186/1472-6882-7-25 CrossRefPubMedPubMedCentral

Balneaves LG, Truant TLO, Kelly M, Verhoef MJ, Davison BJ (2007) Bridging the gap: decision-making processes of women with breast cancer using complementary and alternative medicine (CAM). Support Care Cancer 15(8):973–983. https://doi.org/10.1007/s00520-007-0282-3 CrossRefPubMed

White M, Verhoef M (2006) Cancer as part of the journey: the role of spirituality in the decision to decline conventional prostate cancer treatment and to use complementary and alternative medicine. Integr Cancer Ther 5(2):117–112. https://doi.org/10.1177/1534735406288084 CrossRefPubMed

10.

Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D (2000) Alternative therapies used by women with breast cancer in four ethnic populations. JNCI 92(1):42–47. https://doi.org/10.1093/jnci/92.1.42 CrossRefPubMed

11.

Kakai H, Maskarinec G, Shumay DM, Tatsumura Y, Katsuya T (2003) Ethnic differences in choices of health information by cancer patients using complementary and alternative medicine: an exploratory study with correspondence analysis. Soc Sci Med 56(4):851–862. https://doi.org/10.1016/S0277-9536(02)00086-2 CrossRefPubMed

12.

Chow WH, Chang P, Lee SC, Wong A, Shen HM, Verkooijen HM (2010) Complementary and alternative medicine among Singapore cancer patients. Ann Acad Med Singap 18(1):12–17. https://doi.org/10.1186/s12906-016-1430-4 CrossRef

13.

Statistics Canada (2011) Immigration and ethnocultural diversity in Canada. Statistics Canada catalogue no. 99-010-X2011001. Ottawa. http://www12.statcan.gc.ca/nhs-enm/2011/as-sa/99-010-x/99-010-x2011001-eng.pdf. Accessed 9 Aug 2017

14.

Chen Z, Zheng KGY, Zheng W, Lu W, Shu XO (2008) The use of complementary and alternative medicine among Chinese women with breast cancer. J Altern Complement Med 14(8):1049–1055. https://doi.org/10.1089/acm.2008.0039 CrossRefPubMed

15.

Teng L, Jin K, He K, Bian C, Chen W, Fu K, Zhu T, Jin Z (2010) Use of complementary and alternative medicine by cancer patients at Zhejiang University Teaching Hospital, Zhuji Hospital, China. Afr J Tradit Complement Altern Med 7(4):322–330. https://doi.org/10.4314/ajtcam.v7i4.56699 CrossRefPubMedPubMedCentral

16.

Yang C, Chien LY, Tai CJ (2008) Use of complementary and alternative medicine among patients with cancer receiving outpatient chemotherapy in Taiwan. J Altern Complement Med 14(4):413–416. https://doi.org/10.1089/acm.2007.7181 CrossRefPubMed

17.

Ferro MA, Leis A, Doll R, Chiu L, Chung M, Barroetavena MC (2007) The impact of acculturation on the use of traditional Chinese medicine in newly diagnosed Chinese cancer patients. Support Care Cancer 5(8):985–992. https://doi.org/10.1007/s00520-007-0285-0 CrossRef

18.

Chiu L, Balneaves LG, Barroetavena MC, Doll R, Leis A (2006) Use of complementary and alternative medicine by Chinese individuals living with cancer in British Columbia. J Complement Integr Med 3(1):1553–3840. https://doi.org/10.2202/1553-3840.1037 CrossRef

19.

Balneaves LG, Truant TLO, Verhoef MJ, Ross B, Porcino AJ, Wong ME, Brazier AS (2012) The Complementary Medicine Education and Outcomes (CAMEO) program: a foundation for patient and health professional education and decision support programs. Patient Educ Couns 89(3):461–466. https://doi.org/10.1016/j.pec.2012.01.005 CrossRefPubMed

20.

SPSS (2006) SPSS statistics. Version 15.0. SPSS, Chicago

21.

Hislop TG, Bajdik CD, Regier MD, Barroetavena M (2007) Ethnic differences in survival for female cancers of the breast, cervix and colorectum in British Columbia, Canada. Asian Pac J Cancer Prev 8(2):209–214PubMed

22.

Andersen RM (1995) Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav 36(1):1–10CrossRef

23.

Brown C, Barner J, Bohman T, Richards K (2009) A multivariate test of an expanded Andersen Health Care utilization model for complementary and alternative medicine (CAM) use in African Americans. J Altern Complement Med 15(8):911–919. https://doi.org/10.1089/acm.2008.0561 CrossRefPubMedPubMedCentral

24.

Thorne S (2016) Interpretive description: qualitative research for applied practice. Routledge, New York

25.

Thorne S, Stephens J, Truant T (2016) Building qualitative study design using nursing’s disciplinary epistemology. J Adv Nurs 72(2):451–460. https://doi.org/10.1111/jan.12822 CrossRefPubMed

26.

Lee J, Bell K (2011) The impact of cancer on family relationships among Chinese patients. J Transcult Nurs 22(3):225–234. https://doi.org/10.1177/1043659611405531 CrossRefPubMed

27.

Simpson PB (2003) Family beliefs about diet and traditional Chinese medicine for Hong Kong women with breast cancer. Oncol Nurs Forum 30(5):834–840. https://doi.org/10.1188/03.ONF.834-840 CrossRefPubMed

28.

Shumay DM, Maskarinec G, Kakai H, Gotay CC (2001) Why some cancer patients choose complementary and alternative medicine instead of conventional treatment. J Fam Pract 50(12):1067PubMed

29.

NVivo (2008) NVivo qualitative data analysis software, version 8. QSR International Pty Ltd, Doncaster

30.

Schofield P, Diggens J, Charleson C, Marigliani R, Jefford M (2010) Effectively discussing complementary and alternative medicine in a conventional oncology setting: communication recommendations for clinicians. Patient Educ Couns 79(2):143–115. https://doi.org/10.1016/j.pec.2009.07.038 CrossRefPubMed

31.

Eng JL, Monkman DA, Verhoef MJ, Ramsum DL, Bradbury J (2001) Canadian Cancer Society Information Services: lessons learned about complementary medicine information needs. Chronic Dis Can 22(3–4):102–107PubMed

32.

Zeller T, Muenstedt K, Stoll C, Schweder J, Senf B, Ruckhaeberle E, Becker S, Serve H, Huebner J (2013) Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center. J Cancer Res Clin Oncol 139(3):357–365. https://doi.org/10.1007/s00432-012-1336-6 CrossRefPubMed

33.

Capsi O, Koithan M, Criddle MW (2004) Alternative medicine or “alternative” patients: a qualitative study of patient-oriented decision-making processes with respect to complementary and alternative medicine. Med Decis Mak 24:64–79. https://doi.org/10.1177/027298X03261567 CrossRef

34.

Deng GE, Frenkel M, Cohen L, Cassileth BR, Abrams DI, Capodice JL, Courneya KS, Dryden T, Hanser S, Kumar N, Labriola D, Wardell DW, Sagar S (2009) Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol 7(3):83–84. https://doi.org/10.2310/7200.2009.0019 CrossRef

35.

Greenlee H, Balneaves L, Carlson LE, Cohen M, Deng G, Hershman D, Mumber M, Perlmutter J, Seely D, Sen A, Zick SM, Tripathy D (2014) Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monogr 2014(50):346–358. https://doi.org/10.1093/jncimonographs/lgu041 CrossRefPubMedPubMedCentral

Titel: Complementary and alternative medicine (CAM) information and support needs of Chinese-speaking cancer patients
verfasst von: Lynda G. Balneaves
M. E. Wong
A. J. Porcino
T. L. O. Truant
S. E. Thorne
S. T. Wong
Publikationsdatum: 03.06.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 12/2018
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-018-4288-9

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Complementary and alternative medicine (CAM) information and support needs of Chinese-speaking cancer patients

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2018

Febrile neutropenia in adjuvant and neoadjuvant chemotherapy for breast cancer: a retrospective study in routine clinical practice from a single institution

Reflections on the implementation of screening for distress (sixth vital sign) in Canada: key lessons learned

Meta-analysis of randomized controlled trials of the efficacy of propolis mouthwash in cancer therapy-induced oral mucositis

Youth and parent perceptions of parenting in childhood cancer survivors and healthy peers

Challenges to the design and testing supportive interventions for cancer patients treated with oral oncolytic agents

New insights in radiation-induced leukoencephalopathy: a prospective cross-sectional study

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie